These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 26376805

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression.
    Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, Abi-Jaoude E.
    Int J Risk Saf Med; 2016 Sep 17; 28(3):143-61. PubMed ID: 27662279
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.
    Keller MB, Ryan ND, Strober M, Klein RG, Kutcher SP, Birmaher B, Hagino OR, Koplewicz H, Carlson GA, Clarke GN, Emslie GJ, Feinberg D, Geller B, Kusumakar V, Papatheodorou G, Sack WH, Sweeney M, Wagner KD, Weller EB, Winters NC, Oakes R, McCafferty JP.
    J Am Acad Child Adolesc Psychiatry; 2001 Jul 17; 40(7):762-72. PubMed ID: 11437014
    [Abstract] [Full Text] [Related]

  • 4. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec 17; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 5. Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials.
    Carpenter DJ, Fong R, Kraus JE, Davies JT, Moore C, Thase ME.
    J Clin Psychiatry; 2011 Nov 17; 72(11):1503-14. PubMed ID: 21367354
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of Paroxetine 20 mg daily in the treatment of depression and depression associated anxiety.
    Chaudhry HR, Qureshi Z, Tareen IA, Yazdani I.
    J Pak Med Assoc; 2002 Nov 17; 52(11):518-25. PubMed ID: 12585372
    [Abstract] [Full Text] [Related]

  • 8. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.
    Anghelescu IG, Kohnen R, Szegedi A, Klement S, Kieser M.
    Pharmacopsychiatry; 2006 Nov 17; 39(6):213-9. PubMed ID: 17124643
    [Abstract] [Full Text] [Related]

  • 9. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P.
    Lancet; 2016 Aug 27; 388(10047):881-90. PubMed ID: 27289172
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.
    Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M.
    Curr Med Res Opin; 2006 Jul 27; 22(7):1331-41. PubMed ID: 16834832
    [Abstract] [Full Text] [Related]

  • 12. Paroxetine in the treatment of Chinese patients with depressive episode: a double-blind randomized comparison with imipramine.
    Chiu HJ, Hong CJ, Chan CH.
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jun 27; 57(6):418-23. PubMed ID: 8803304
    [Abstract] [Full Text] [Related]

  • 13. Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial.
    Rapaport MH, Lydiard RB, Pitts CD, Schaefer D, Bartolic EI, Iyengar M, Carfagno M, Lipschitz A.
    J Clin Psychiatry; 2009 Jan 27; 70(1):46-57. PubMed ID: 19026248
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies.
    Delle Chiaie R, Pancheri P, Scapicchio P.
    Am J Clin Nutr; 2002 Nov 27; 76(5):1172S-6S. PubMed ID: 12418499
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
    Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT, Pollock BG, Gaffney A, Narayan M, Finkel MS, McCafferty J, Gergel I.
    JAMA; 1998 Jan 28; 279(4):287-91. PubMed ID: 9450712
    [Abstract] [Full Text] [Related]

  • 20. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
    Lee P, Shu L, Xu X, Wang CY, Lee MS, Liu CY, Hong JP, Ruschel S, Raskin J, Colman SA, Harrison GA.
    Psychiatry Clin Neurosci; 2007 Jun 28; 61(3):295-307. PubMed ID: 17472599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.